Amplifon (BIT:AMP) Reports Mixed Earnings, Is The Rebound Already Priced In?
Amplifon (BIT:AMP) is back in focus after reporting mixed earnings for the second quarter and first half of 2026. The company posted modestly higher Q2 sales and net income, alongside weaker year to date profitability.
See our latest analysis for Amplifon.
Amplifon’s mixed first half earnings update appears to have reset expectations, with the share price at €12.15 after a 1 month share price return of 23.18% and a 90 day share price return of 29.26%. However, the 1 year total shareholder return is down 15.87% and the 5 year total shareholder return is down 68.98%, which points to recent momentum building from a weak longer term base.
If you are weighing Amplifon’s rebound against other opportunities in the market, this could be a good moment to broaden your watchlist and check out 106 top founder-led companies
Recent gains have arrived alongside mixed earnings, which raises a simple point for Amplifon shareholders. Is this rebound mainly a catch up in sentiment, or does the current price already reflect the business fundamentals on offer?
Most Popular Narrative: 6.3% Undervalued
The most followed Amplifon narrative currently points to a fair value of €12.97, slightly above the last close at €12.15. This frames the recent rebound in a different light for investors comparing price to narrative assumptions.
The current market weakness in Europe and the US is largely attributed to cyclical macroeconomic headwinds, pent-up demand from aging populations, and the five-year hearing aid replacement cycle. Once market volatility recedes and returning customer cohorts normalize, Amplifon is described as poised to benefit from an underlying structural rise in demand, supporting potential revenue acceleration.
Curious what sits underneath that fair value for Amplifon. The narrative leans heavily on a step up in earnings power and a richer margin profile. The key question is how those profit assumptions, growth expectations and discount rate all line up to reach that number.
Result: Fair Value of €12.97 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this Amplifon narrative still faces real pressure from softer organic sales trends and a heavier debt load, which could strain future earnings resilience.
Find out about the key risks to this Amplifon narrative.
Another View on Amplifon’s Valuation
While the most followed narrative sees Amplifon as modestly undervalued, the current P/E of 46.7x tells a different story. It sits well above the peer average of 25.5x and a fair ratio of 33x, which points to richer pricing and higher valuation risk if expectations slip.
That contrast leaves an important question for you as an investor: Is the recent rebound a reasonable price for Amplifon’s growth plans, or are you paying too much for a recovery that still needs to show through in cleaner earnings?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals on Amplifon can be confusing, so this is a good time to move quickly, review the data yourself, and weigh both the 2 key rewards and 6 important warning signs
Looking for more investment ideas beyond Amplifon?
If Amplifon has your attention, do not stop there. Broaden your watchlist now so you are not leaving potential opportunities on the table.
- Target resilient income by reviewing companies described as 430 dividend fortresses that may appeal if you value consistency alongside yield.
- Spot potential value opportunities early by scanning 257 high quality undervalued stocks where pricing and quality can occasionally line up in your favor.
- Focus on financial strength first by checking the solid balance sheet and fundamentals stocks screener (412 results) to see which stocks pair sturdier balance sheets with solid fundamentals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com